Form 4: Agios Pharmaceuticals Officer Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Theodore James Jr. Washburn, Principal Accounting Officer of Agios Pharmaceuticals, sold shares to cover tax obligations related to vesting restricted stock units.
Summary
- On February 1, 2025, Theodore James Jr. Washburn, Principal Accounting Officer of Agios Pharmaceuticals, exercised restricted stock units, acquiring 6,896 shares of common stock.
- On February 5, 2025, Washburn sold 2,272 shares at a price of $34.39 per share to cover tax withholding obligations.
- Following these transactions, Washburn directly owns 5,437 shares of Agios Pharmaceuticals common stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral as the filing reflects routine transactions related to executive compensation and tax obligations.
Industry Context
Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives and are generally viewed as routine.
Key Dates
| Date | Description |
|---|---|
| February 1, 2023 | Date of the restricted stock unit agreement. |
| February 1, 2025 | Date of restricted stock units vesting and acquisition of shares. |
| February 5, 2025 | Date of sale of shares to cover tax obligations. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.